These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21380782)
1. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma. Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas]. Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221 [TBL] [Abstract][Full Text] [Related]
3. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
4. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1. Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue. Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198 [TBL] [Abstract][Full Text] [Related]
7. Expression and significance of the Wip1 proto-oncogene in colorectal cancer. Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302 [TBL] [Abstract][Full Text] [Related]
8. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients. Lee HY; Ahn JB; Rha SY; Chung HC; Park KH; Kim TS; Kim NK; Shin SJ World J Surg Oncol; 2014 Jul; 12():232. PubMed ID: 25060774 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma. Evertsson S; Bartik Z; Zhang H; Jansson A; Sun XF Int J Oncol; 1999 Jul; 15(1):53-8. PubMed ID: 10375593 [TBL] [Abstract][Full Text] [Related]
10. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival. Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889 [TBL] [Abstract][Full Text] [Related]
12. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735 [TBL] [Abstract][Full Text] [Related]
13. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer. Qu L; Liang L; Su J; Yang Z Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094 [TBL] [Abstract][Full Text] [Related]
15. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes. Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329 [TBL] [Abstract][Full Text] [Related]
16. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Wang X; Wang J; Ma H; Zhang J; Zhou X Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519 [TBL] [Abstract][Full Text] [Related]
18. The roles of JK-1 (FAM134B) expressions in colorectal cancer. Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512 [TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular biologic characteristics of early-onset versus late-onset colorectal carcinoma in Filipinos. Uy GB; Kaw LL; Punzalan CK; Querol RI; Koustova EV; Bowyer MW; Hobbs CM; Sobin LH; Wherry DC World J Surg; 2004 Feb; 28(2):117-23. PubMed ID: 14708047 [TBL] [Abstract][Full Text] [Related]
20. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients. Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]